ArticleBMC cancer2025
Fertility, gonadal and sexual function in survivors of nasopharyngeal carcinoma patients.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeTherapy with radiotherapy in the head and neck, can be associated with gonadal damage in male survivors of cancer. To the authors's knowledge the effect of treatments on testicular reproductive and endocrine function in nasopharyngeal carcinoma (NPC) patients has not been established.
methodsA retrospective study of NPC analyzed hormone levels, semen parameters, sexual functioning, fertility outcome before treatment and treatment after 0, 3, 6, and 12 months.
resultsThe incidence of NPC is high in Sichuan (9.5/100,000). Pre-treatment, 79.4% of NPC patients were normozoospermic. NPC were associated with worse total sperm number compared to healthy controls. There was no significant difference on sperm concentration between differentiated keratinizing group and undifferentiated non-keratinizing group. Post-treatment analyses showed that first-line treatments worsened at 0, 3 and 6 months after the end of treatment (T0, T3, T6), with total sperm number returning to previous level at 12 months. Sexual functions were not significantly impacted by treatment modalities, except for poorer the problem assessment of drive, erection, and ejaculation problems (DEE problems). Fertility data were available for 44 patients: Seven patients (15.9%) desired children after treatment. Six patients achieved fatherhood: 4 through natural conception and 2 following artificial reproductive techniques (ART).
conclusionsTo the authors' knowledge, this is the first time reported the study on fertility preservation in patients with NPC. Following the azoospermia/ oligospermia induced by personalized chemotherapy regimen with NPC, spermatogenesis May take 1-2 years to recover. Nasopharyngeal cancer treatment can affect erectile dysfunction. Awareness of this issue will enable oncologists to better inform patients about the possibility of recovering fertility post-treatment and also demonstrates the importance of semen cryobanking before beginning cancer treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.